Cullinan Oncology Inc. (CGEM)

NASDAQ: CGEM · Real-Time Price · USD

8.81

0.29 (3.40%)

At close: May 02, 2025, 3:59 PM

8.79

-0.28%

After-hours: May 02, 2025, 04:20 PM EDT

Cullinan Oncology Cash Flow Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Net Income	-167.57M	-153.16M	109.19M	-67.48M	-59.46M	-21.65M	-14.19M
Depreciation & Amortization	306K	310K	93K	53K	62K	70K	43K
Stock-Based Compensation	37.82M	30.44M	27.96M	24.38M	14.91M	17K	n/a
Other Working Capital	423K	-172K	11.69M	1.29M	1.27M	-504K	120K
Other Non-Cash Items	-15.47M	-11.52M	-275.08M	67K	7.63M	539K	252K
Deferred Income Tax	n/a	n/a	n/a	3.1M	233K	-4K	n/a
Change in Working Capital	-389K	-339K	11.18M	-3.54M	6.85M	135K	345K
Operating Cash Flow	-145.3M	-134.28M	-126.66M	-43.43M	-29.77M	-20.9M	-13.55M
Capital Expenditures	n/a	-208K	-1.13M	-589.23K	-10K	-20K	-261K
Cash Acquisitions	n/a	-36.01K	275M	923K	1.45M	n/a	n/a
Purchase of Investments	-721.13M	-373.38M	-377.92M	-525.81M	-69.76M	-35.38M	n/a
Sales Maturities Of Investments	584.82M	409.4M	352.93M	192.04M	62.9M	n/a	n/a
Other Investing Acitivies	n/a	36.01K	91K	-333.77K	-5.41K	-35.38K	n/a
Investing Cash Flow	-136.31M	35.81M	248.97M	-333.77M	-5.42M	-35.4M	-261K
Debt Repayment	n/a	1.82M	-2.2M	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	-378K	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	3.54M	538K	-23.73M	1.52M	n/a	1.84M	-9K
Financial Cash Flow	266.19M	40.75M	-25.93M	268.78M	140.14M	85.72M	-29K
Net Cash Flow	-15.43M	-57.72M	96.38M	-108.42M	104.95M	29.42M	-13.84M
Free Cash Flow	-145.3M	-134.48M	-127.8M	-44.02M	-29.78M	-20.92M	-13.81M